Albaron Partners Completes Sale of Prime Psychiatry to Beacon Behavioral Partners

Prime Psychiatry to Continue Its Growth as Part of Beacon Behavioral Partners

NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Albaron Partners, LP ("Albaron"), a middle-market private equity firm, is pleased to announce that it has completed the sale of Prime Wellness LLC d/b/a Prime Psychiatry ("Prime Psychiatry"), a Texas-based leader in outpatient and interventional psychiatry services, to Beacon Behavioral Partners ("Beacon").

In 2022, Albaron partnered with Dr. Efosa Airuehia, founder of Prime Psychiatry, to grow the practice into a regional leader in outpatient and interventional psychiatric care. As part of Beacon's national behavioral health platform, Prime Psychiatry will expand its established Texas presence, positioning both companies for their next phase of growth. "We've greatly valued our partnership with Dr. Airuehia in building Prime Psychiatry into what it is today," said Debo Adesina, partner at Albaron. "We believe that joining Beacon's platform will further accelerate Prime Psychiatry's ability to scale its clinical offerings to patients across Texas and beyond."

Cozen O'Connor P.C. served as sell-side legal counsel to Albaron and Prime Psychiatry, while Citizens Capital Markets & Advisory acted as sell-side financial advisor on the transaction.

About Prime Psychiatry

With operations in DFW and Austin, TX, Prime Psychiatry is a regional leader in outpatient psychiatric services for children, adolescents, and adults. Prime Psychiatry offers various treatment options including anxiety treatment, depression treatment, medication management, TMS, and Spravato (https://primepsychiatrymd.com).

About Beacon

Beacon Behavioral Partners is a physician-driven organization supporting a growing network of independent psychiatric practices across the U.S. They partner with providers to deliver exceptional behavioral healthcare in their communities by removing operational burdens, investing in smart growth, and upholding clinical autonomy. With decades of healthcare management experience and a commitment to data-driven decision-making, their mission is to set the standard for interventional psychiatry through trusted local practices, accountable leadership, and continuous innovation. Beacon helps partners scale sustainably while focusing on what matters most: delivering high-quality, patient-centered care (beaconbhpartners.com).

About Albaron

Founded in 2017, Albaron is an operationally focused, middle-market healthcare private equity firm. Its dedicated team of healthcare investors and seasoned operators partners with founders and management teams to scale their businesses and build leading platforms within their respective specialties. Albaron is currently investing out of its latest fund, a $185 million vehicle that closed in May 2026 (https://albaronpartners.com).

View original content:https://www.prnewswire.com/news-releases/albaron-partners-completes-sale-of-prime-psychiatry-to-beacon-behavioral-partners-302871027.html

SOURCE Albaron Partners